PerpEquities

Equity · Healthcare

BeOne Medicines AG (STAR Market shares) (BEIGENE) perpetual futures

BEIGENE perpetual futures on 1 crypto exchanges – live perp price vs the stock, funding rate, open interest and where to trade BEIGENEUSDT.

BeOne Medicines AG is a Basel-based oncology company developing and commercializing cancer therapies such as BRUKINSA, TEVIMBRA and PARTRUVIX in the United States, China, Europe and other markets.

$43.06+0.5%
Open in terminal

Price chart

 

Use the left and right arrow keys to inspect points on the chart.

venue perp mark · Gate.io (BEIGENE/USDT)
Auto: highest-volume live perp venueOpen in TradingView

Trading data

Perpetual market activity

1/1 live markets
Venues
1
Live markets
1/1
24h volume
$280
Open interest
$2.8K
Best liquidity
$385.2
Gate.io
Tightest spread
+125.5 bps
Gate.io
Highest volume
$280
Gate.io
Settlement mix
USDT · 1/1
Perp/spot vol.
0.00x
Spot volume $50.6M
OI / float
0.00%
Float $38B
Spot performance
1D-0.21%
5D+8.31%
1M+14.21%
6M+15.09%
YTD+6.05%
1Y+1.68%

Venue matrix

1 markets

Some venue links are sponsored. We may receive a commission, and eligible users may occasionally receive trading-fee discounts, at no additional cost to you.

Trade
Gate.ioTradeBEIGENE/USDTTrading$43.060.0% APR
0.000% every 8h
+125.5 bps$385.2$280$2.8KUSDT20x

Tradability

Execution quality

Entry cost and depth per venue at $1k–$100k

No sufficient depth · 0 of 1 venues absorb $10k

No fresh book data: Gate.io

Taker execution estimate incl. approx. fees - maker fills are not guaranteed.

Best venues for this underlying

Best liquidity

BEIGENE

Tightest spread

BEIGENE

Highest volume

BEIGENE

Funding history

Stored venue snapshots by market

Company financials

Financials at a glance

Last report Q3 '26 · filed 2026-09-30 · next report 2027-03-31 · Updated 7h ago
All financials →

Valuation & key figures

Market cap
$44.3B
Updated 7h ago
Revenue
$6.6B
Trailing 12 months
Revenue growth
+23%
Next fiscal year
Profit margin
+13.8%
P/E
67.6
Peer P/E 29.6
P/S
6.7
Peer P/E
29.6
Similar listed perps
Free cash flow
$1.4B
Trailing 12 months
Net income
$917.9M
Trailing 12 months
Revenue estimate
$6.7B
Next fiscal year
Earnings
2027-03-31
Revenue est. $1.9B · Updated 7h ago
Dividend
-
Revenue (TTM)$6.64B+31.8% vs a year agoLast 4 quarters; bars = each quarter
Operating margin (TTM)17.8%+14.6 pp vs a year agoOperating income $1.18B
Net income (TTM)$918M+1,036.9% vs a year agoAfter tax, incl. non-operating gains
Free cash flow (TTM)$1.44B+209.2% vs a year agoCapex $162M
Diluted EPS (TTM)$0.60-90.3% vs a year agoSum of the last 4 quarters
Net cash$4.63B+53.5% vs a year agoCash + short-term investments - debt
  • Revenue growth accelerating: 33.8% year on yearQ3 '26 revenue $1.89B, against an average of 32.2% over the four quarters before.
  • Operating margin 17.8% (TTM), +14.6 pp on a year agoOperating income grew 633.8% while revenue grew 31.8%.
  • Capex 2.4% of revenue (a year ago 6.4%)$162M invested in the last 4 quarters (-49.6% on a year earlier). Free cash flow $1.44B = 156.5% of net income.
  • Diluted share count up 1,231.6% in a year1.52B diluted shares in Q3 '26, 115M a year earlier.

Revenue, operating income and growth

quarterly
In the full financialsIncome statement, balance sheet and cash flow (12 quarters / 10 years) · margins and cost structure · capital allocation and buybacks · valuation against the 5-year range · analyst estimates

Next catalyst

Catalysts

Earnings
2027-03-31
Revenue est. $1.9B · Updated 7h ago

No unusual perp activity right now.

Research data

Analysts, filings and peer context

Estimates

6
DateEPS estimateRevenue estimateGrowthAnalysts
FY 20260.56$6.7B+23%4
FY 20270.79$7.8B+42%5
FY 20281.05$8.9B+62%2
FY 20291.23$9.8B+78%1
FY 20301.50$11.1B+102%1
Q1 20270.15$1.7B+15%1

Company events

6
2027-03-31EarningsActual - / Estimate 1.25-
2026-11-06EarningsActual 1.67 / Estimate 0.98Beat
2026-11-05EarningsActual 1.67 / Estimate 0.98Beat
2026-08-05EarningsActual 1.06 / Estimate 0.86Beat
2026-05-06EarningsActual 1.02 / Estimate 0.56Beat
2026-02-26EarningsActual 0.33 / Estimate 0.67Miss

Peer comparison

Similar listed perps

Company data

Company intelligence

Updated: Nov 2, 2026, 05:15 PM UTC

Company profile

Sector
Healthcare
Industry
Biotechnology
Chief executive
John V. Oyler
Employees
12,000
IPO date
Dec 15, 2021
Country
CH
Exchange
Shanghai Stock Exchange
Website
Altman Z-scorei6.4
Piotroski scorei6/9
Overall ratingiB-
Owner earningsi$599.69M$0.40 per share

Rating factors

Return on equityi
4
Return on assetsi
4
Debt to equityi
2
Price to earningsi
2
Price to booki
1
Market cap history
CN¥363.33B+0.9%Aug 26 – Nov 26
CN¥359.75BCN¥397.30BCN¥434.84BHigh: CN¥434.84B · 2026-08-10Low: CN¥359.75B · 2026-10-12Latest: CN¥363.33B · 2026-11-02Aug 26Sep 26Oct 26Nov 26
Latest: CN¥363.33B · 2026-11-02High: CN¥434.84B · 2026-08-10Low: CN¥359.75B · 2026-10-12
Largest fund holders
FundWeightShares held
VWO0%131.4K
VXUS0%114.3K
2823.HK0.16%68.6K
VEU0%34.9K
82822.HK0.15%32.1K
FTWG.L0.02%26.9K
FTWD.L0.02%26.5K
EMGF0.04%20.2K
VWRA.L0%12.6K
VT0%7.7K
SEMR.MI0.02%6.4K
NBCE1.2%4.8K

Analyst track record

How the analysts covering BEIGENE have done: ratings, price-target accuracy and the measured reaction after their calls.

12 months3 years
Ratings00
Analysts00
Buy / hold / sell––
Upgrades / downgrades / initiations0 / 0 / 00 / 0 / 0
Price targets hit / missed––
Avg. return after a rating (TipRanks)––
Best / worst call– / –– / –

After buy calls on this stock: not enough measured cases yet

TipRanks data · computed Nov 5, 2026 · 0 ratings

Frequently asked questions

Where can I trade BEIGENE perpetual futures?

BeOne Medicines AG (STAR Market shares) (BEIGENE) perpetual futures trade on 1 crypto venues, including Gate.io. PerpEquities compares them by live price, funding rate, open interest and liquidity.

Can I trade BEIGENE around the clock?

Yes. Unlike the underlying stock, BEIGENE perpetuals trade 24/7 — including weekends and outside regular market hours.

What is the funding rate on BEIGENE perpetuals?

Right now the BEIGENE perp funding rate is 0.0% annualized (venue median), ranging from 0.0% to 0.0% across 1 venues. A positive rate means longs pay shorts. PerpEquities shows the live rate and its history for every venue.

How does the BEIGENE perp price compare to the BeOne Medicines AG (STAR Market shares) stock?

The venue-median BEIGENE perp mark is $43.1 versus a reference stock price of $43.1, a basis of 0.0%. Perps follow the stock through an index price; the gap widens when funding or liquidity diverge between venues.

What is a BEIGENE perpetual future?

A BEIGENE perpetual is a derivative that tracks the price of BeOne Medicines AG (STAR Market shares) with no expiry date. It lets you take long or short exposure to BeOne Medicines AG (STAR Market shares) on crypto venues, around the clock.

What is BEIGENEUSDT perpetual?

BEIGENEUSDT is the symbol most crypto exchanges use for the BeOne Medicines AG (STAR Market shares) perpetual settled in USDT (Tether). It tracks the BEIGENE share price through an index, trades 24/7 with leverage and never expires.

Embed this asset

BEIGENE perpetuals · perpequities.comBEIGENE perpetuals · perpequities.com
<a href="https://perpequities.com/stocks/beigene-perp"><img src="https://perpequities.com/badge/beigene-perp.svg" width="240" height="64" alt="BEIGENE perpetuals · perpequities.com" loading="lazy"></a>

Next step

Stay on top of BEIGENE perps

Signals with a track record

Analysts who hit 70%+ of their targets on the perps we track, congress buys over $500k, 13F positions over $5M, funding spreads that have paid for days. Every post shows the evidence. Free, no sign-up.

Join on Telegram

Weekly digest by email

The listings, funding and moves that matter for BEIGENE — one email every Sunday.

Watchlist and alerts

Price and funding alerts for BEIGENE, via push or Telegram.

Set an alert

Follow the live feed

Daily movers, new listings and funding extremes as they happen.

Follow on X